Evidence map›Paper›PMID 41706466›Full record

ArticleDalton transactions (Cambridge, England : 2003)2026

Inhibition of PHPT1 by phenylarsonic acids.

E Dalles Keyes, Sophia E Hollow, Paul Oblad, Timothy C Johnstone, Amy M Barrios

Abstract read
In one paragraph

Article in Dalton transactions (Cambridge, England : 2003), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

E Dalles KeyesDepartment of Biochemistry, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84112, USA. Amy.Barrios@Utah.edu.ORCID http://orcid.org/0000-0002-1495-5890
Sophia E HollowDepartment of Chemistry and Biochemistry, University of California Santa Cruz, USA.
Paul ObladDepartment of Chemistry, College of Science, University of Utah, USA.
Timothy C JohnstoneDepartment of Chemistry and Biochemistry, University of California Santa Cruz, USA.ORCID http://orcid.org/0000-0003-3615-4530
Amy M BarriosDepartment of Biochemistry, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City, UT 84112, USA. Amy.Barrios@Utah.edu.ORCID http://orcid.org/0000-0003-2739-9261

Funding

Out of the shadows: Illuminating mammalian histidine phosphorylationR35GM153175 · NIGMS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI AMY M BARRIOS · 2024 to 2026
$1.2M
Using Inorganic Chemistry to Understand and Solve Health-Related ProblemsR35GM154824 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Timothy Charles Johnstone · 2024 to 2026
$1.1M
NIGMS NIH HHS R35 GM153175NIGMS NIH HHS R35 GM154824
6 · The paper itself

Abstract

The human protein histidine phosphatase PHPT1 is involved in several important cellular pathways and has been implicated in various cancers. However, the biological roles of this enzyme are not well understood due to a lack of chemical tools that enable its study. Herein we have identified phenylarsonic acids as general scaffolds which inhibit PHPT1 activity. Notably, phenylarsonic acids can be embedded into peptide sequences, providing the first known peptide-based inhibitors of PHPT1. In a counterscreen against a small panel of phosphatases, we demonstrate that these compounds exhibit some selectivity for PHPT1. Moreover, we show that these compounds exhibit mixed inhibition. We provide evidence that reduction of the phenylarsonic acids

Indexed as

ArsenicalsEnzyme InhibitorsPhosphoric Monoester HydrolasesHumansArsenicalsEnzyme InhibitorsPhosphoric Monoester Hydrolases

Identifiers

PMID41706466
PMCPMC12915710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.